As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
Site Selection Mistakes: What Not To Do
High-Performance EFCO Systems Shape MUSC's New Black River Medical Center
Heritage Valley Health System to Officially Affiliate with Alleghany Health Network
The Impact of Acoustics on Patient Privacy
Texas Behavioral Health Center in Dallas Opens with Ribon-Cutting Ceremony